Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Foundayo and Wegovy pill comparison brief overview Foundayo (orforglipron, by Eli Lilly) and the Wegovy pill (oral semaglutide, by Novo Nordisk) are both once-daily GLP-1 receptor agonist tablets approved for chronic weight management in adults with obesity or overweight
North Carolina removed GLP-1s from its preferred drug list for weight loss in October 2025, though coverage for cardiovascular and other non-obesity indications continues with prior authorization
So the savings arent hitting your wallet on day one
We addressed this with weekly "flow sessions" to improve mobility and prevent injury and a maintainable schedule of workouts
The key to lasting weight loss lies in a combined approach
Samir Rahmani for a personalised recommendation
US$ 22.78
US$ 25.18
US$ 29.00
US$ 22.61
